Sensei Biotherapeutics Inc
SNSE
Market Cap$9.65M
Close$
$0.24
97.1% downside
Current Fair Value
97.1% downsideOvervalued by 97.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $9.65 Million |
|---|---|
| Enterprise Value | $2.99 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.2 |
| Beta | 0.1 |
| Outstanding Shares | 25,192,363 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6.65 |
|---|---|
| PEG | 47.1 |
| Price to Sales | - |
| Price to Book Ratio | 8.38 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.1 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.07 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Sensei Biotherapeutics Inc
31 employeesSensei Biotherapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company has developed a p...